G.L.O.W.: A Novel Hybrid Neural Network Approach for Glioblastoma Localization Using Carcinogenic Oxidative Stress Biomarkers
ISEF · 2024 Computational Biology and Bioinformatics
Overview
Oxidative stress is a precursor to numerous cancers, including the Grade IV glioblastoma, affecting >300,000 people annually. However, the identification of oxidative stress markers remains incomplete. Effective treatment requires both localizing minuscule tumors and predicting their growth to determine the optimal stage for removal. Our wet lab results showed a 311% increase in glyceraldehyde-3-dehydrogenase (GAPDH) expression, a glycolysis enzyme fueling tumors, and an oxidative stress marker, after radiation. This highlights the connection to cancer through high Optical Density suggesting rapid cell proliferation, indicating potential carcinogenesis. With this association, utilizing a neural network approach allows us to get insights more rapidly. We developed the “Glioblastoma Localization and Optimization Workbench (G.L.O.W)” a novel neural conduit that integrates deep-learning and histone modification factors via ChIP-seq genomics and QUEST MRI, an MRI designed to visualize oxidative redox, to model cancer through a spatial/temporal approach. G.L.O.W. deciphers the spatial distribution of carcinogenic biomarkers (e.g., glycolysis enzymes for energy production) and their genetic precursors to predict the precise location of the tumor. Our model is 98% accurate for localization and carcinogenesis identification for growths scaled upwards from 13 micrometers. G.L.O.W. predicted tumor growth over 50 weeks using longitudinal data, achieving F1 scores from 0.75 to 0.91, surpassing all other clinical diagnostics. Our model also achieved mutation identification of critical tumor-related genes including causative factors for targeted therapies. G.L.O.W. enables us to locate minuscule tumors for early diagnosis while being cost-effective and time-efficient.
Competition history
- ISEF 2024
Resources
Related projects
ISEF · 2018
GlioVision: A Platform for the Automatic Assessment of Glioblastoma Tumor Features, Molecular Identity, and Gene Methylation from Histopathological Images Using Deep Learning
ISEF · 2022
Artificial Intelligence Solution for Effective Treatment Planning for Brain Tumor Patients
ISEF · 2023
Personalized Neurooncology Radiogenomic Classification and Recommendation Model With AI and MRI
ISEF · 2024
GB-NeuroAnalysis AI: Early Diagnosis of Glioblastoma Multiforme in MRI Images Through a Novel End-to-End Deep Learning Pipeline
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair